![Olivier Tillement](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Olivier Tillement is the founder of NH TherAguix SAS, holding the title of Director since 2019, founded in 2015.
Dr. Tillement was the founder of Mexbrain SAS, having held the title of Chief Scientific Officer, founded in 2017.
Dr. Tillement is currently a Professor at Université Claude Bernard Lyon 1.
Aktive Positionen von Olivier Tillement
| Unternehmen | Position | Beginn |
|---|---|---|
| NH THERAGUIX SAS | Gründer | 11.12.2015 |
Université Claude Bernard Lyon 1
 Université Claude Bernard Lyon 1 Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Olivier Tillement
| Unternehmen | Position | Ende |
|---|---|---|
Mexbrain SAS
 Mexbrain SAS Medical SpecialtiesHealth Technology Manufactures therapeutic dialysis devices for metal extraction | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
19
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Université Claude Bernard Lyon 1
Université Claude Bernard Lyon 1 Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NH TherAguix SAS
 NH TherAguix SAS Pharmaceuticals: MajorHealth Technology Operates as a clinical stage pharmaceutical company that develops nanomedicine for cancer, combining imaging and radiotherapy | Health Technology |
Mexbrain SAS
Mexbrain SAS Medical SpecialtiesHealth Technology Manufactures therapeutic dialysis devices for metal extraction | Health Technology |
